The myopic phenotype in children with inherited retinal disease – key insights from a UAE series
This study of 51 children with inherited retinal disease in the UAE reveals that while reduced visual acuity and nyctalopia/photophobia are the most common presenting features, traditional "red flag" criteria for secondary myopia such as high myopia before age 10 or myopia exceeding chronological age are present in only a minority of cases, suggesting that overreliance on refractive data alone may lead to missed diagnoses.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Every child who struggles to see distant objects clearly is often diagnosed with nearsightedness, a common condition where the eye focuses images in front of the retina rather than directly on it. While most cases of childhood nearsightedness are a straightforward developmental issue, a small but significant number of children develop this vision problem as a symptom of a deeper, inherited disease affecting the light-sensitive tissue at the back of the eye. These underlying conditions, known as inherited retinal diseases, can cause the eye to malfunction in ways that go far beyond simple blurriness, sometimes leading to night blindness or sensitivity to bright light. Distinguishing between a child who simply needs glasses and one who has a serious genetic disorder is a critical task for doctors, because the latter group requires genetic counseling, monitoring for other health issues, and specialized care that standard vision correction cannot provide.
For years, medical guidelines have relied on specific rules of thumb to flag children who might have these hidden retinal diseases. The most common warning signs have been the development of severe nearsightedness before a child turns ten, or a prescription that is stronger than the child's age would suggest. The logic was that such extreme vision changes were unlikely to happen by chance and likely pointed to a deeper problem. However, a new study from a major hospital in the United Arab Emirates challenges the reliability of these rules. By looking closely at a group of children who were already confirmed to have inherited retinal diseases, researchers found that the very signs doctors use to screen for these conditions were missing in the majority of cases.
The research team at Cleveland Clinic Abu Dhabi reviewed the medical records of 51 children, all under the age of eighteen, who had been diagnosed with these inherited eye disorders and also had nearsightedness. The study covered a five-year period, allowing the doctors to track how the children's vision changed over time. They examined not just the strength of the children's glasses prescriptions, but also their visual acuity, family history, and specific symptoms like difficulty seeing in the dark or discomfort in bright light. The goal was to see how often the standard "red flags" actually appeared in this group of children who were known to have the disease.
The results revealed a pattern that contradicts the common screening criteria. While every single child in the study had reduced vision and most reported trouble seeing at night or sensitivity to light, only a small fraction showed the severe nearsightedness that guidelines typically look for. Specifically, only about one-third of the children developed high levels of nearsightedness before turning ten, and an even smaller group had a prescription that exceeded their age in strength. In other words, if a doctor were to rely solely on the rule that "severe nearsightedness before age ten means check for retinal disease," they would have missed nearly two-thirds of the children in this study who actually had the condition. The most consistent signs were not the numbers on a glasses prescription, but the child's inability to see clearly and their complaints about seeing poorly in the dark.
The researchers also looked at how fast the children's vision worsened over time. They found that the rate at which the nearsightedness progressed was generally modest and did not differ significantly from what is seen in children with common, non-genetic nearsightedness. This suggests that once the vision problem is established in these children, it does not necessarily spiral out of control faster than in other kids, but the underlying cause remains a serious genetic issue. The study identified the specific genetic causes for each child, finding that a wide variety of genes were involved, with one particular gene variant being the most common. This genetic diversity further complicates the picture, as different mutations can lead to similar vision problems but might not follow the same predictable path.
The implications of these findings are significant for how doctors evaluate children with vision problems. The study suggests that placing too much trust in the strength of a child's glasses prescription can lead to a dangerous delay in diagnosis. If a child has nearsightedness that seems mild or moderate, or if the prescription does not exceed their age, they might be sent home with standard glasses and never investigated for the underlying retinal disease. This delay can postpone access to emerging gene therapies and prevent families from getting the genetic counseling they need. The authors emphasize that the most reliable indicators are the child's actual ability to see and their history of night blindness or light sensitivity.
This work does not claim to have solved the mystery of how to diagnose every case, nor does it suggest that the old rules are entirely useless. Rather, it highlights that the current screening tools are incomplete. The study was conducted at a specialized hospital, which means the children seen there might represent more severe cases than those in a general clinic, and the researchers noted that they did not have a direct comparison group of children with simple nearsightedness to measure against. Despite these limitations, the data is clear: the clinical picture of inherited retinal disease in children is often subtler than previously thought. The most important takeaway is that doctors must look beyond the numbers on a prescription and listen carefully to the child's experience and the family's history to catch these conditions early.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.